CLCollPlant Biotechnologies Ltd. CLGN · NASDAQ
$3.62 -3.60% (-$0.14)
- Market cap
- $4.69M
- Enterprise value
- $4.40M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 14.8x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -221.3%
- Bruto marža
- -521.7%
- Neto marža
- -3,934.9%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- -
- Beta
- 0.76
- Free float
- 75.8%
O podjetju
CollPlant Biotechnologies Ltd. (CLGN) is a biotechnology company operating in the field of regenerative medicine. The company focuses on the development and production of biological materials and collagen-based products for the treatment of various health conditions. CollPlant employs advanced technologies in creating bioinks and 3D printing for tissue and organ generation. The company emphasizes innovation and product development that could contribute to improvements in patient care. CollPlant Biotechnologies Ltd. (CLGN) shares could be an intriguing choice for investors interested in the biotechnology sector and regenerative medicine.
Sector
Healthcare
Industry
Biotechnology
CEO
Yehiel Tal
Employees
39
Headquarters
Rehovot
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke